Science

High concordance of serological methods for EBV staging

A new collaborative study by Euroimmun and researchers in Türkiye reports that both ELISA and immunoblot show excellent agreement with the reference standard — indirect immunofluorescence assay (IFA) — for serological staging of Epstein-Barr virus (EBV) infections. A widespread infection EBV is a ubiquitous herpesvirus that infects more than 95% of the global population, usually […]

Science

Robust performance of serological tests for coeliac disease in Tunisia

Serological tests for coeliac disease-specific antibodies showed exceptionally high sensitivity and specificity in a Tunisian cohort, underscoring their diagnostic utility. The recently published findings stem from a collaborative study between Euroimmun and various laboratories in Tunisia. Studying a unique population Coeliac disease is an autoimmune disorder triggered in genetically predisposed individuals by gluten ingestion. It

Science

Clarity on the floor: differentiating dermal-binding autoantibodies

A newly published international study has demonstrated the high sensitivity of the Euroimmun Dermal Binder Mosaic 1 for detecting antibodies against laminin β4, laminin 332 and collagen type VII. The prospective multicentre study represents the latest milestone in a long-standing research collaboration between Euroimmun and the University of Lübeck, Germany. Shedding light on anti-laminin β4

Science

On the trail of anti-laminin β4 autoantibodies

A collaboration driving discovery A long-standing research collaboration between Euroimmun and the University of Lübeck, Germany has led to major advances in understanding anti-p200 pemphigoid, a rare autoimmune skin blistering disease. Recent publications from the collaborative team have identified laminin subunit beta 4 (laminin β4) as a key autoantigen, demonstrated the pathogenic effects of anti-laminin

Products, Science

New patterns in ANA diagnostics

With passion for rheumatology! Recently, three new fluorescence patterns were added to the classification tree of the International Consensus on Antinuclear Antibody Patterns (ICAP)1. ICAP is an initiative of international scientists with the goal of evaluating the large number of ANA patterns in a standardised way. ANA (antinuclear antibodies) are biomarkers for different autoimmune diseases,

Scroll to Top